News from atheronova inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 30, 2014, 07:00 ET

AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Dec 05, 2013, 07:00 ET

AtheroNova Completes Enrollment in Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Oct 15, 2013, 07:00 ET

Atherosclerosis Researcher Dr. Erik Stroes Joins AtheroNova's Clinical Advisory Board

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Sep 19, 2013, 07:00 ET

AtheroNova to Present at the 2013 Aegis Healthcare Conference in Las Vegas

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Jun 27, 2013, 08:00 ET

AtheroNova Announces Publication of Positive Pre-Clinical Results with AHRO-001 in the FASEB Journal

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Jun 25, 2013, 07:00 ET

AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

May 30, 2013, 08:01 ET

AtheroNova Announces Shipment of Phase 1 Drug Product

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

May 09, 2013, 07:00 ET

AtheroNova Announces Approval for Phase 1 by the Russian Ministry of Healthcare with Commencement of Human Trials Imminent

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Apr 15, 2013, 13:37 ET

Noted Atherosclerosis Researcher Joins AtheroNova Team

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Apr 11, 2013, 07:00 ET

AtheroNova Adds New Medical Advisor

 AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Mar 14, 2013, 18:18 ET

AtheroNova Announces Shareholder Realignment

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Jan 17, 2013, 07:00 ET

AtheroNova to Present at Noble Financial Capital Markets' Ninth Annual Equity Conference

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Jan 08, 2013, 08:00 ET

AtheroNova Names New Clinical Affairs Officer

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Dec 18, 2012, 08:00 ET

AtheroNova Names New Chief Medical Officer

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Nov 15, 2012, 07:22 ET

AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic...

Nov 13, 2012, 08:00 ET

AtheroNova Announces Milestone Filing of IND in Russian Federation

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Nov 07, 2012, 08:22 ET

AtheroNova Names New Director

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Oct 11, 2012, 09:26 ET

AtheroNova Completes $2.9 Million Private Placement of Common Stock

 AtheroNova Inc. (OTCBB: AHRO) ("AtheroNova"), a biotech company focused on the research and development of compounds to regress...

Oct 09, 2012, 08:49 ET

Additional Study to Commence at The David Geffen School of Medicine at the University of California Los Angeles (UCLA)

 AtheroNova Inc. (OTCBB: AHRO) ("AtheroNova"), a biotech company focused on the research and development of compounds to regress...

Sep 25, 2012, 08:34 ET

AtheroNova to Present at the 2012 Aegis Healthcare Conference in Las Vegas

 AtheroNova Inc. (OTCBB: AHRO) ("AtheroNova"), a biotech company focused on the research and development of compounds to regress...